JP Morgan Chase
BIO icon

JP Morgan Chase’s Bio-Rad Laboratories Class A BIO Stock Holding History

JP Morgan Chase’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-18,100
Closed -$5.53M – 5768
2019
Q1 		$5.53M Buy
+18,100
New +$4.88M ﹤0.01% 2507

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase's BIO Position: Q2 2026 in Review

JP Morgan Chase increased its Bio-Rad Laboratories Class A (BIO) stake by 3.2% in Q2 2026, buying an estimated $912K and bringing the position to 102,605 shares worth $30.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1863.

JP Morgan Chase first reported a position in BIO in Q2 2013 and has held it in 53 quarters since. The position peaked at $33.2M in Q2 2021. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • JP Morgan Chase held 102,605 shares of Bio-Rad Laboratories Class A worth $30.5M as of Q2 2026.
  • JP Morgan Chase bought 3,214 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $912K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1863 holding.
  • JP Morgan Chase first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Bio-Rad Laboratories Class A position peaked at $33.2M in Q2 2021.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.